Xylem financials
$100.93+0.02%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.34B | $2.13B | $2.40B | $2.27B | $2.30B | $2.07B | $2.26B | $2.10B | $2.17B | $2.03B | $2.12B | $2.08B |
| Gross profit | $963.0M | $803.0M | $932.0M | $883.0M | $892.0M | $768.0M | $857.0M | $784.0M | $819.0M | $752.0M | $756.0M | $764.0M |
| Gross margin | 41.2% | 37.8% | 38.9% | 38.9% | 38.8% | 37.1% | 38.0% | 37.3% | 37.8% | 37.0% | 35.7% | 36.8% |
| Operating income | $390.0M | $244.0M | $353.0M | $334.0M | $305.0M | $231.0M | $267.0M | $280.0M | $253.0M | $209.0M | $211.0M | $191.0M |
| Net income | $263.0M | $193.0M | $335.0M | $227.0M | $226.0M | $169.0M | $326.0M | $217.0M | $194.0M | $153.0M | $266.0M | $152.0M |
| Net margin | 11.3% | 9.1% | 14.0% | 10.0% | 9.8% | 8.2% | 14.5% | 10.3% | 8.9% | 7.5% | 12.6% | 7.3% |
| Diluted EPS | $1.11 | $0.79 | $1.37 | $0.93 | $0.93 | $0.69 | $1.34 | $0.89 | $0.80 | $0.63 | $1.10 | $0.63 |
| EBITDA | $541.0M | $415.0M | $529.0M | $499.0M | $476.0M | $397.0M | $434.0M | $425.0M | $421.0M | $353.0M | $230.0M | $359.0M |
| Operating cash flow | $290.0M | $108.0M | $543.0M | $360.0M | $305.0M | $33.0M | $575.0M | $311.0M | $288.0M | $89.0M | $455.0M | $373.0M |
| Free cash flow | $201.0M | $18.0M | $497.0M | $244.0M | $207.0M | -$38.0M | $475.0M | $237.0M | $215.0M | $15.0M | $361.0M | $299.0M |
| Diluted shares | 236.6M | 243.4M | 244.2M | 244.1M | 243.9M | 243.8M | 243.8M | 243.8M | 243.5M | 243.0M | 242.5M | 242.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.28B | $808.0M | $1.48B | $1.19B | $1.17B | $1.06B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.93B | $1.94B | $1.94B | $1.96B | $2.00B | $2.02B |
| Total assets | $17.34B | $16.95B | $17.63B | $17.30B | $17.19B | $16.56B |
| Total liabilities | $6.68B | $5.72B | $5.88B | $5.85B | $5.88B | $5.50B |
| Shareholders' equity | $10.42B | $10.98B | $11.49B | $11.22B | $11.08B | $10.82B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology